MedAssets 13th Annual Business and Technology Forum Drives Collaboration and Innovation Among Healthcare Supply Chain Leaders

ATLANTA, Nov. 7, 2014 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq:MDAS) recently held its 13th annual Business and Technology Forum in Dallas, Texas. The goal of the Business and Technology Forum is to drive industry collaboration and share innovation between healthcare providers and suppliers of quality healthcare products and services. Key event highlights included:

  • The Technology and Innovation Expo (Expo). Enabled more than 75 distributors and manufacturers to showcase the latest advancements in clinical technologies and other new healthcare products and services to approximately 400 MedAssets provider clients.
  • The introduction of Sg2, a MedAssets company. Sg2 provides analytics and insights to both supplier and provider executives as they build strategies to capture future business opportunities within dynamic local, regional and national markets.
  • The debut of new supplier-facing services from MedAssets. New services include a mobile technology platform to facilitate high-quality procurement interaction between healthcare suppliers and clinical decision makers.

Expo Showcases Technology and Clinical Advancements

Each year, the Expo affords suppliers the opportunity to exhibit the newest innovations and trends in healthcare based on several criteria including: quantifiable reductions in supply chain cost; significant technological or clinical advancements, and opportunity to improve patient outcomes and the overall delivery of patient care. Suppliers that receive a high score from attending MedAssets provider clients and that meet contracting eligibility guidelines, will continue through the standard sourcing process for consideration to be added to the MedAssets national contract portfolio, which is comprised of more than 1,200 companies.

"The MedAssets Business and Technology Forum provided our system the opportunity to share practical and repeatable best practices for sustainable process improvements with our peers, collaborate with suppliers and engage in executive networking opportunities," said Clinton Hazziez, director, Corporate Supply Chain, Cancer Treatment Centers of America. "Essential to the effective and efficient delivery of quality care is the ability to gain access to the industry's most innovative products and services. The Technology and Innovation Expo is a crucial event for CTCA as we are always looking for the latest advancements in healthcare to better serve our patients and our communities."

"MedAssets has been instrumental in facilitating high quality interactions between suppliers and clinical decision makers," said Gwyn Selby, director, National Accounts, ACell, Inc. "The Business and Technology Forum is an important event for our company to build business relationships with hospital executives and to have high-level discussions about exploring the value we can all create beyond price."

A Commitment to Promote Best Practice Processes to Address Today's Industry Challenges

"Facilitating industry innovation and improvement to enhance the standard of care is core to the MedAssets business mission," said Keith Thurgood, president, Spend and Clinical Resource Management, MedAssets. "MedAssets is proud to support the successful collaboration between industry stakeholders. This year's Business and Technology Forum provided an effective venue for attendees to discuss how best to reduce costs, improve utilization and compliance, create new efficiencies and streamline payment operations for total performance improvement in the quality and cost of care."

About MedAssets

MedAssets (Nasdaq:MDAS) is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics to help reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the care continuum. For more information, please visit


CONTACT: Media Contact: Robin Wrinn 678.624.7420 Investor Contact: Robert Borchert 678.248.8194